Pharmacogenetic Assessment of Toxicity and Outcome in Patients With Metastatic Colorectal Cancer Treated With LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000-05Valérie Boige, Pierre Laurent‐Puig, Jean‐Pierre Pignon et al.|Journal of Clinical Oncology|2010Cited by 169
The cellular prion protein controls the mesenchymal-like molecular subtype and predicts disease outcome in colorectal cancerDelphine Le Corre, Sophie Mouillet‐Richard|EBioMedicine|2019Cited by 50